Page 60 - AN-1-1

Advanced Neurology EPAC2 null leads to tauopathy

391-401. https://doi.org/10.1038/ncb1528
https://doi.org/10.1007/s12035-014-9007-z 32. Jadhav S, Cubinkova V, Zimova I, et al., 2015, Tau-mediated
synaptic damage in Alzheimer’s disease. Transl Neurosci,
21. Greenberg SG, Davies P, 1990, A preparation of Alzheimer 6(1): 214–226.
paired helical filaments that displays distinct tau proteins by
polyacrylamide gel electrophoresis. Proc Natl Acad Sci U S A, https://doi.org/10.1515/tnsci-2015-0023
87(15): 5827–5831. 33. Wang JZ, Grundke-Iqbal I, Iqbal K, 2007, Kinases
https://doi.org/10.1073/pnas.87.15.5827 and phosphatases and tau sites involved in Alzheimer
neurofibrillary degeneration. Eur J Neurosci, 25(1): 59-68.
22. Wang JZ, Liu F, 2008, Microtubule-associated protein tau in
development, degeneration and protection of neurons. Prog https://doi.org/10.1111/j.1460-9568.2006.05226.x
Neurobiol, 85(2): 148-175. 34. Götz J, Nitsch RM, 2001, Compartmentalized tau
https://doi.org/10.1016/j.pneurobio.2008.03.002 hyperphosphorylation and increased levels of kinases in
transgenic mice. Neuroreport, 12(9): 2007–2016.
23. Shukla V, Skuntz S, Pant HC, 2012, Deregulated Cdk5
activity is involved in inducing Alzheimer’s disease. Arch https://doi.org/10.1097/00001756-200107030-00045
Med Res, 43(8): 655–662. 35. Liu T, Perry G, Chan HW, et al., 2004, Amyloid-beta-
https://doi.org/10.1016/j.arcmed.2012.10.015 induced toxicity of primary neurons is dependent upon
differentiation-associated increases in tau and cyclin-
24. Novais F, Starkstein S, 2015, Phenomenology of depression dependent kinase 5 expression. J Neurochem, 88(3):
in Alzheimer’s disease. J Alzheimers Dis, 47(4): 845–855.
554–563.
https://doi.org/10.3233/JAD-148004 https://doi.org/10.1046/j.1471-4159.2003.02196.x
25. Wang X, Wang ZH, Wu YY, et al., 2013, Melatonin 36. Castro-Alvarez JF, Uribe-Arias SA, Mejia-Raigosa D,
attenuates scopolamine-induced memory/synaptic disorder et al., 2014, Cyclin-dependent kinase 5, a node protein in
by rescuing EPACs/miR-124/Egr1 pathway. Mol Neurobiol, diminished tauopathy: A systems biology approach. Front
47(1): 373-3781. Aging Neurosci, 6: 232.
https://doi.org/10.1007/s12035-012-8355-9 https://doi.org/10.3389/fnagi.2014.00232
26. Jones KA, Sumiya M, Woolfrey KM, et al., 2019, Loss of 37. Lopes JP, Oliveira CR, Agostinho P, 2010, Neurodegeneration
EPAC2 alters dendritic spine morphology and inhibitory in an Abeta-induced model of Alzheimer’s disease: The role
synapse density. Mol Cell Neurosci, 98: 19-31. of Cdk5. Aging Cell, 9(1): 64-77.
https://doi.org/10.1016/j.mcn.2019.05.001 https://doi.org/10.1111/j.1474-9726.2009.00536.x
27. Yang X, Yao C, Tian T, et al., 2018, A novel mechanism 38. Lee MS, Kwon YT, Li M, et al., 2000, Neurotoxicity induces
of memory loss in Alzheimer’s disease mice via the cleavage of p35 to p25 by calpain. Nature, 405(6784): 360–364.
degeneration of entorhinal-CA1 synapses. Mol Psychiatry,
23(2): 199-210. https://doi.org/10.1038/35012636
https://doi.org/10.1038/mp.2016.151 39. Liu F, Su Y, Li B, et al., 2003, Regulation of amyloid precursor
protein (APP) phosphorylation and processing by p35/Cdk5
28. Woolfrey KM, Srivastava DP, Photowala H, et al., 2009, and p25/Cdk5. FEBS Lett, 547(1-3): 193-196.
Epac2 induces synapse remodeling and depression and its
disease-associated forms alter spines. Nat Neurosci, 12(10): https://doi.org/10.1016/s0014-5793(03)00714-2
1275–1284. 40. Joshi G, Bekier ME 2 , Wang Y, 2015, Golgi fragmentation
nd
https://doi.org/10.1038/nn.2386 in Alzheimer’s disease. Front Neurosci, 9: 340.
29. Wu M, Zhang M, Yin X, et al., 2021, The role of pathological https://doi.org/10.3389/fnins.2015.00340
tau in synaptic dysfunction in Alzheimer’s diseases. Transl 41. McBrayer M, Nixon RA, 2013, Lysosome and calcium
Neurodegener. 10(1): 45. dysregulation in Alzheimer’s disease: partners in crime.
https://doi.org/10.1186/s40035-021-00270-1 Biochem Soc Trans, 41(6): 1495–1502.
30. Wang Y, Mandelkow E, 2016, Tau in physiology and https://doi.org/10.1042/BST20130201
pathology. Nat Rev Neurosci, 17(1): 5-21. 42. Ferreira A, 2012, Calpain dysregulation in Alzheimer’s
https://doi.org/10.1038/nrn.2015.1 disease. ISRN Biochem, 2012: 728571.
https://doi.org/10.5402/2012/728571
31. Fulga TA, Elson-Schwab I, Khurana V, et al., 2007, Abnormal
bundling and accumulation of F-actin mediates tau-induced 43. Camins A, Verdaguer E, Folch J, et al., 2006, involvement
neuronal degeneration in vivo. Nat Cell Biol, 9(2): 139–148. of calpain activation in neurodegenerative processes. CNS

Volume 1 Issue 1 (2022) 11 https://doi.org/10.36922/an.v1i1.8